Intrinsic value of Acadia Healthcare - ACHC

Previous Close

$46.90

  Intrinsic Value

$44.82

stock screener

  Rating & Target

hold

-4%

  Value-price divergence*

+21%

Previous close

$46.90

 
Intrinsic value

$44.82

 
Up/down potential

-4%

 
Rating

hold

 
Value-price divergence*

+21%

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of ACHC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 4.1

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  56.69
  10.00
  9.50
  9.05
  8.64
  8.28
  7.95
  7.66
  7.39
  7.15
  6.94
  6.74
  6.57
  6.41
  6.27
  6.14
  6.03
  5.93
  5.83
  5.75
  5.68
  5.61
  5.55
  5.49
  5.44
  5.40
  5.36
  5.32
  5.29
  5.26
  5.24
Revenue, $m
  2,811
  3,092
  3,386
  3,692
  4,011
  4,344
  4,689
  5,048
  5,421
  5,809
  6,212
  6,631
  7,066
  7,520
  7,991
  8,482
  8,993
  9,526
  10,082
  10,662
  11,267
  11,899
  12,559
  13,249
  13,970
  14,724
  15,513
  16,339
  17,203
  18,109
  19,057
Variable operating expenses, $m
 
  2,595
  2,816
  3,047
  3,287
  3,537
  3,797
  4,067
  4,348
  4,640
  4,943
  4,991
  5,318
  5,659
  6,014
  6,384
  6,769
  7,170
  7,588
  8,025
  8,480
  8,955
  9,452
  9,971
  10,514
  11,082
  11,676
  12,297
  12,948
  13,629
  14,343
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  2,418
  2,595
  2,816
  3,047
  3,287
  3,537
  3,797
  4,067
  4,348
  4,640
  4,943
  4,991
  5,318
  5,659
  6,014
  6,384
  6,769
  7,170
  7,588
  8,025
  8,480
  8,955
  9,452
  9,971
  10,514
  11,082
  11,676
  12,297
  12,948
  13,629
  14,343
Operating income, $m
  393
  497
  569
  645
  724
  806
  892
  981
  1,073
  1,169
  1,269
  1,640
  1,748
  1,860
  1,977
  2,098
  2,225
  2,357
  2,494
  2,638
  2,787
  2,944
  3,107
  3,277
  3,456
  3,642
  3,838
  4,042
  4,256
  4,480
  4,714
EBITDA, $m
  528
  848
  929
  1,013
  1,101
  1,192
  1,287
  1,385
  1,487
  1,594
  1,704
  1,819
  1,939
  2,063
  2,193
  2,327
  2,468
  2,614
  2,766
  2,925
  3,091
  3,265
  3,446
  3,635
  3,833
  4,040
  4,256
  4,483
  4,720
  4,969
  5,229
Interest expense (income), $m
  161
  189
  211
  234
  258
  283
  309
  337
  365
  394
  425
  457
  490
  524
  560
  597
  635
  676
  718
  762
  807
  855
  905
  957
  1,011
  1,068
  1,127
  1,190
  1,255
  1,323
  1,394
Earnings before tax, $m
  33
  308
  359
  411
  466
  523
  583
  644
  708
  775
  844
  1,184
  1,258
  1,336
  1,417
  1,501
  1,589
  1,681
  1,776
  1,876
  1,980
  2,089
  2,202
  2,321
  2,445
  2,574
  2,710
  2,852
  3,001
  3,157
  3,320
Tax expense, $m
  29
  83
  97
  111
  126
  141
  157
  174
  191
  209
  228
  320
  340
  361
  383
  405
  429
  454
  480
  507
  535
  564
  595
  627
  660
  695
  732
  770
  810
  852
  896
Net income, $m
  6
  225
  262
  300
  340
  382
  425
  470
  517
  565
  616
  864
  919
  975
  1,035
  1,096
  1,160
  1,227
  1,297
  1,369
  1,445
  1,525
  1,607
  1,694
  1,785
  1,879
  1,978
  2,082
  2,191
  2,304
  2,424

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  57
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,025
  6,565
  7,189
  7,839
  8,517
  9,222
  9,956
  10,718
  11,510
  12,333
  13,189
  14,078
  15,003
  15,965
  16,966
  18,009
  19,094
  20,226
  21,406
  22,637
  23,922
  25,263
  26,665
  28,129
  29,660
  31,262
  32,937
  34,690
  36,525
  38,447
  40,460
Adjusted assets (=assets-cash), $m
  5,968
  6,565
  7,189
  7,839
  8,517
  9,222
  9,956
  10,718
  11,510
  12,333
  13,189
  14,078
  15,003
  15,965
  16,966
  18,009
  19,094
  20,226
  21,406
  22,637
  23,922
  25,263
  26,665
  28,129
  29,660
  31,262
  32,937
  34,690
  36,525
  38,447
  40,460
Revenue / Adjusted assets
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
  0.471
Average production assets, $m
  2,278
  2,505
  2,743
  2,991
  3,249
  3,518
  3,798
  4,089
  4,391
  4,705
  5,032
  5,371
  5,724
  6,091
  6,473
  6,870
  7,285
  7,716
  8,167
  8,636
  9,126
  9,638
  10,173
  10,732
  11,316
  11,927
  12,566
  13,235
  13,935
  14,668
  15,436
Working capital, $m
  85
  68
  74
  81
  88
  96
  103
  111
  119
  128
  137
  146
  155
  165
  176
  187
  198
  210
  222
  235
  248
  262
  276
  291
  307
  324
  341
  359
  378
  398
  419
Total debt, $m
  3,288
  3,633
  4,032
  4,448
  4,882
  5,333
  5,803
  6,290
  6,797
  7,324
  7,872
  8,441
  9,033
  9,649
  10,289
  10,957
  11,651
  12,376
  13,131
  13,919
  14,741
  15,599
  16,496
  17,434
  18,414
  19,438
  20,511
  21,633
  22,807
  24,037
  25,326
Total liabilities, $m
  3,857
  4,202
  4,601
  5,017
  5,451
  5,902
  6,372
  6,859
  7,366
  7,893
  8,441
  9,010
  9,602
  10,218
  10,858
  11,526
  12,220
  12,945
  13,700
  14,488
  15,310
  16,168
  17,065
  18,003
  18,983
  20,007
  21,080
  22,202
  23,376
  24,606
  25,895
Total equity, $m
  2,168
  2,363
  2,588
  2,822
  3,066
  3,320
  3,584
  3,858
  4,144
  4,440
  4,748
  5,068
  5,401
  5,747
  6,108
  6,483
  6,874
  7,281
  7,706
  8,149
  8,612
  9,095
  9,599
  10,126
  10,678
  11,254
  11,857
  12,488
  13,149
  13,841
  14,566
Total liabilities and equity, $m
  6,025
  6,565
  7,189
  7,839
  8,517
  9,222
  9,956
  10,717
  11,510
  12,333
  13,189
  14,078
  15,003
  15,965
  16,966
  18,009
  19,094
  20,226
  21,406
  22,637
  23,922
  25,263
  26,664
  28,129
  29,661
  31,261
  32,937
  34,690
  36,525
  38,447
  40,461
Debt-to-equity ratio
  1.517
  1.540
  1.560
  1.580
  1.590
  1.610
  1.620
  1.630
  1.640
  1.650
  1.660
  1.670
  1.670
  1.680
  1.680
  1.690
  1.700
  1.700
  1.700
  1.710
  1.710
  1.720
  1.720
  1.720
  1.720
  1.730
  1.730
  1.730
  1.730
  1.740
  1.740
Adjusted equity ratio
  0.354
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360
  0.360

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  6
  225
  262
  300
  340
  382
  425
  470
  517
  565
  616
  864
  919
  975
  1,035
  1,096
  1,160
  1,227
  1,297
  1,369
  1,445
  1,525
  1,607
  1,694
  1,785
  1,879
  1,978
  2,082
  2,191
  2,304
  2,424
Depreciation, amort., depletion, $m
  135
  352
  360
  368
  376
  385
  395
  404
  414
  425
  436
  179
  191
  203
  216
  229
  243
  257
  272
  288
  304
  321
  339
  358
  377
  398
  419
  441
  464
  489
  515
Funds from operations, $m
  339
  577
  621
  668
  717
  767
  820
  875
  931
  990
  1,052
  1,043
  1,109
  1,178
  1,250
  1,325
  1,403
  1,484
  1,569
  1,657
  1,750
  1,846
  1,947
  2,052
  2,162
  2,277
  2,397
  2,523
  2,655
  2,793
  2,938
Change in working capital, $m
  -22
  6
  6
  7
  7
  7
  8
  8
  8
  9
  9
  9
  10
  10
  10
  11
  11
  12
  12
  13
  13
  14
  15
  15
  16
  17
  17
  18
  19
  20
  21
Cash from operations, $m
  361
  570
  615
  661
  710
  760
  812
  867
  923
  982
  1,043
  1,034
  1,100
  1,169
  1,240
  1,314
  1,392
  1,472
  1,557
  1,645
  1,736
  1,832
  1,932
  2,037
  2,146
  2,260
  2,380
  2,505
  2,636
  2,773
  2,917
Maintenance CAPEX, $m
  0
  -76
  -83
  -91
  -100
  -108
  -117
  -127
  -136
  -146
  -157
  -168
  -179
  -191
  -203
  -216
  -229
  -243
  -257
  -272
  -288
  -304
  -321
  -339
  -358
  -377
  -398
  -419
  -441
  -464
  -489
New CAPEX, $m
  -348
  -227
  -238
  -248
  -259
  -269
  -280
  -291
  -302
  -314
  -326
  -339
  -353
  -367
  -382
  -398
  -414
  -432
  -450
  -470
  -490
  -512
  -535
  -559
  -584
  -611
  -639
  -669
  -700
  -733
  -768
Cash from investing activities, $m
  -660
  -303
  -321
  -339
  -359
  -377
  -397
  -418
  -438
  -460
  -483
  -507
  -532
  -558
  -585
  -614
  -643
  -675
  -707
  -742
  -778
  -816
  -856
  -898
  -942
  -988
  -1,037
  -1,088
  -1,141
  -1,197
  -1,257
Free cash flow, $m
  -299
  268
  294
  322
  352
  383
  415
  449
  485
  521
  560
  527
  568
  611
  655
  701
  748
  798
  849
  903
  958
  1,016
  1,076
  1,139
  1,204
  1,272
  1,343
  1,417
  1,495
  1,576
  1,660
Issuance/(repayment) of debt, $m
  -277
  380
  399
  416
  434
  451
  469
  488
  507
  527
  548
  569
  592
  616
  641
  667
  695
  724
  755
  788
  822
  859
  897
  937
  980
  1,025
  1,072
  1,122
  1,175
  1,230
  1,288
Issuance/(repurchase) of shares, $m
  676
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  359
  380
  399
  416
  434
  451
  469
  488
  507
  527
  548
  569
  592
  616
  641
  667
  695
  724
  755
  788
  822
  859
  897
  937
  980
  1,025
  1,072
  1,122
  1,175
  1,230
  1,288
Total cash flow (excl. dividends), $m
  46
  647
  693
  738
  785
  834
  885
  937
  992
  1,048
  1,107
  1,096
  1,160
  1,226
  1,296
  1,368
  1,443
  1,522
  1,604
  1,691
  1,780
  1,875
  1,973
  2,076
  2,184
  2,297
  2,415
  2,539
  2,669
  2,806
  2,949
Retained Cash Flow (-), $m
  -485
  -217
  -225
  -234
  -244
  -254
  -264
  -274
  -285
  -296
  -308
  -320
  -333
  -346
  -360
  -375
  -391
  -407
  -425
  -443
  -463
  -483
  -504
  -527
  -551
  -576
  -603
  -631
  -661
  -692
  -725
Prev. year cash balance distribution, $m
 
  22
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  452
  468
  504
  541
  580
  621
  663
  706
  752
  799
  776
  827
  880
  935
  993
  1,053
  1,115
  1,180
  1,247
  1,318
  1,392
  1,469
  1,549
  1,633
  1,721
  1,812
  1,908
  2,009
  2,114
  2,224
Discount rate, %
 
  9.60
  10.08
  10.58
  11.11
  11.67
  12.25
  12.86
  13.51
  14.18
  14.89
  15.64
  16.42
  17.24
  18.10
  19.01
  19.96
  20.96
  22.00
  23.10
  24.26
  25.47
  26.75
  28.08
  29.49
  30.96
  32.51
  34.13
  35.84
  37.63
  39.51
PV of cash for distribution, $m
 
  412
  386
  373
  355
  334
  310
  284
  256
  228
  199
  157
  133
  111
  91
  73
  57
  44
  33
  24
  17
  12
  8
  5
  3
  2
  1
  1
  0
  0
  0
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. The company’s acute inpatient psychiatric facilities offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities include residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs. It also provides outpatient community-based services, such as community-based programs that are designed to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder. In addition, the company offers mental health services; rehabilitation services comprising relapse prevention and social integration services, as well as vocational opportunities; acute services for patients at risk to themselves or others, as well as crisis intervention and treatment of behavioral emergencies; and care homes, which provide long-term and non-acute care for adults suffering from mental illness, addiction, learning disability, or brain injury. Further, it provides other services that include education and children’s services for children and young people with special educational needs; adult and elderly care services; and care first services for employees. At December 31, 2016, the company operated a network of 573 behavioral healthcare facilities with approximately 17,100 beds. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.

FINANCIAL RATIOS  of  Acadia Healthcare (ACHC)

Valuation Ratios
P/E Ratio 677.6
Price to Sales 1.4
Price to Book 1.9
Price to Tangible Book
Price to Cash Flow 11.3
Price to Free Cash Flow 312.8
Growth Rates
Sales Growth Rate 56.7%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 14.9%
Cap. Spend. - 3 Yr. Gr. Rate 35.2%
Financial Strength
Quick Ratio 2
Current Ratio 0.1
LT Debt to Equity 150%
Total Debt to Equity 151.7%
Interest Coverage 1
Management Effectiveness
Return On Assets 0.5%
Ret/ On Assets - 3 Yr. Avg. 4%
Return On Total Capital 0.1%
Ret/ On T. Cap. - 3 Yr. Avg. 3.1%
Return On Equity 0.3%
Return On Equity - 3 Yr. Avg. 7.1%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 0%
Gross Margin - 3 Yr. Avg. 0%
EBITDA Margin 11.7%
EBITDA Margin - 3 Yr. Avg. 16.3%
Operating Margin 14%
Oper. Margin - 3 Yr. Avg. 15%
Pre-Tax Margin 1.2%
Pre-Tax Margin - 3 Yr. Avg. 7.6%
Net Profit Margin 0.2%
Net Profit Margin - 3 Yr. Avg. 4.9%
Effective Tax Rate 87.9%
Eff/ Tax Rate - 3 Yr. Avg. 51.6%
Payout Ratio 0%

ACHC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the ACHC stock intrinsic value calculation we used $2811 million for the last fiscal year's total revenue generated by Acadia Healthcare. The default revenue input number comes from 2016 income statement of Acadia Healthcare. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our ACHC stock valuation model: a) initial revenue growth rate of 10% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 9.6%, whose default value for ACHC is calculated based on our internal credit rating of Acadia Healthcare, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Acadia Healthcare.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of ACHC stock the variable cost ratio is equal to 84.8%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for ACHC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.8% for Acadia Healthcare.

Corporate tax rate of 27% is the nominal tax rate for Acadia Healthcare. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the ACHC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for ACHC are equal to 81%.

Life of production assets of 34.7 years is the average useful life of capital assets used in Acadia Healthcare operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for ACHC is equal to 2.2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2168 million for Acadia Healthcare - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 87.305 million for Acadia Healthcare is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Acadia Healthcare at the current share price and the inputted number of shares is $4.1 billion.

RELATED COMPANIES Price Int.Val. Rating
AAC AAC Holdings 9.05 5.61  hold
NHC National Healt 61.78 31.55  str.sell
KND Kindred Health 7.70 11.18  hold
UHS Universal Heal 107.99 131.06  hold
ENSG Ensign Group 19.61 27.35  buy
CSU Capital Senior 11.85 1.00  str.sell

COMPANY NEWS

▶ Acadia Healthcare beats 2Q profit forecasts   [Jul-27-17 09:54PM  Associated Press]
▶ Mount Carmel picks for-profit joint venture partner to build $26M psychiatric hospital   [Jul-24-17 04:57PM  American City Business Journals]
▶ State approves for-profit firms new hospital in partnership with University of Miami   [Jun-05-17 03:15PM  American City Business Journals]
▶ Acadia Healthcare to Present at Three Upcoming Conferences   [Apr-27-17 11:00AM  Business Wire]
▶ Acadia Healthcare meets 1Q profit forecasts   [Apr-25-17 04:49PM  Associated Press]
▶ Acadia Healthcare Set to Join the S&P MidCap 400   [Apr-03-17 06:07PM  PR Newswire]
▶ New Strong Sell Stocks for March 1st   [Mar-01-17 09:34AM  Zacks]
▶ [$$] BC Partners Completes Purchase of Acadia Healthcare Facilities   [Nov-30-16 06:49PM  at The Wall Street Journal]
Stock chart of ACHC Financial statements of ACHC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.